A Study to Evaluate Pre-operative HYPOfractionated Radiation Therapy in Aged (≥ 70 Years Old) or "Fragile" (≥ 65 Years) Patients With Limb or Trunk Soft Tissue SARComa.

Patients' disease-free survival defined as the time between the inclusion date and the occurrence of a carcinological event (local recurrence, distant metastasis) or death from any cause.

Time frame: 3 years for each patient

Surgical complications evaluated according to NCI CTC AE V5 criteria.

Time frame: 3 years for each patient

Wound disorders, such as partial necrosis and scar disunion, classified into four categories: severe, moderate, minor, absent.

Time frame: 3 years for each patient

Healing time defined as the time between the date of surgery and the date of complete healing.

Time frame: 3 years for each patient

Patients' quality of life evaluated using the EORTC questionnaire (QLQ-C30).

Time frame: 3 years for each patient

Patients' quality of life evaluated using the EORTC questionnaire (QLQ-ELD14).

Time frame: 3 years for each patient

Patient autonomy evaluated using the IADL (Instrumental Activities of Daily Living) questionnaire.

Time frame: 3 years for each patient

Geriatric parameters evaluated using the G8 (Geriatric 8) questionnaire.

Time frame: 3 years for each patient

Geriatric parameters evaluated using the G-CODE questionnaire.

Time frame: 3 years for each patient

Toxicities of the radiation therapy evaluated according to NCI CTC AE V5 criteria and Radiation Therapy Oncology Group (RTOG) classification.

Time frame: 3 years for each patient